Literature DB >> 2585441

Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent.

R McCague1, G Leclercq, N Legros, J Goodman, G M Blackburn, M Jarman, A B Foster.   

Abstract

A range of tamoxifen derivatives substituted in the 4-position of the 1-phenyl ring are described. The key steps in the synthesis of 4-iodo-, 4-bromo-, and 4-(methylthio)tamoxifen were reactions of 1,2-diarylbutanones with the (4-halogenophenyl)lithium or [4-(methylthio)phenyl]magnesium bromide. Oxidized precursors of 4-(methylthio)tamoxifen were used to prepare the methylsulfinyl and methylsulfonyl derivatives. Further derivatives (formyl, hydroxymethyl, oxirane, mercapto) were prepared from 4-bromotamoxifen via the 4-lithio derivative. Several of the derivatives (Br, I, SMe, SOMe, SO2Me, oxirane, CHO, CH2OH) displayed a higher affinity for estrogen receptors (ER) of calf uterine cytosol than did tamoxifen, but there was no relationship between affinity to ER and the ability to inhibit the growth of the MCF-7 breast cancer cell line in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585441     DOI: 10.1021/jm00132a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Highly Stereoselective Synthesis of Tetrasubstituted Acyclic All-Carbon Olefins via Enol Tosylation and Suzuki-Miyaura Coupling.

Authors:  Beryl X Li; Diane N Le; Kyle A Mack; Andrew McClory; Ngiap-Kie Lim; Theresa Cravillion; Scott Savage; Chong Han; David B Collum; Haiming Zhang; Francis Gosselin
Journal:  J Am Chem Soc       Date:  2017-07-26       Impact factor: 15.419

2.  Electrospray ionization mass spectrometry for analysis of low-molecular-weight anticancer drugs and their analogues.

Authors:  G K Poon; G M Bisset; P Mistry
Journal:  J Am Soc Mass Spectrom       Date:  1993-07       Impact factor: 3.109

3.  Synthesis and biological evaluation of novel tamoxifen-1,2,4-triazole conjugates.

Authors:  M S R Murty; Mohana Rao Katiki; Jagadeesh Babu Nanubolu; Srujana Garimella; Sowjanya Polepalli; Nishant Jain; Sudheer Kumar Buddana; R S Prakasham
Journal:  Mol Divers       Date:  2016-06-08       Impact factor: 2.943

4.  Lithium Hexamethyldisilazide-Mediated Enolization of Highly Substituted Aryl Ketones: Structural and Mechanistic Basis of the E/Z Selectivities.

Authors:  Kyle A Mack; Andrew McClory; Haiming Zhang; Francis Gosselin; David B Collum
Journal:  J Am Chem Soc       Date:  2017-08-23       Impact factor: 15.419

5.  Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer.

Authors:  S R Johnston; B P Haynes; N P Sacks; J A McKinna; L J Griggs; M Jarman; M Baum; I E Smith; M Dowsett
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

6.  Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cells.

Authors:  Wayne Childers; Rong Fan; Rogelio Martinez; Dennis J Colussi; Edward Melenski; Yuxiao Liu; John Gordon; Magid Abou-Gharbia; Marlene A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2019-11-11       Impact factor: 2.823

Review 7.  Endocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?

Authors:  Stephen R D Johnston
Journal:  Breast Cancer Res       Date:  2005-04-06       Impact factor: 6.466

8.  Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.

Authors:  P Pace; M Jarman; D Phillips; A Hewer; J Bliss; R C Coombes
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

Authors:  S R Johnston; S Riddler; B P Haynes; R A'Hern; I E Smith; M Jarman; M Dowsett
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.

Authors:  S Y Sharp; M G Rowlands; M Jarman; L R Kelland
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.